As translational CRISPR-based research continues to make waves in laboratories and the clinic, scientists across life science disciplines pursue out-of-the-ordinary genome editing applications. From ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Caribou Biosciences Inc. (CRBU) stock has tumbled to a 52-week low, touching down at $1.49. This latest price point marks a significant drop for the biotechnology company, which has experienced a ...

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

Truist Financial analyst Nicole Germino maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of ...

The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...

Genetic changes have the ability to alter crop characteristics, and some crop breeding techniques take advantage of this.

MGX stock is soaring Wednesday on the heels of the company’s involvement with OpenAI and SoftBank’s (SFTBY) new Stargate ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

Scientists from a collaboration of Australian research institutions have proposed that editing multiple genetic variants in ...